Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision		 Previous revision
conjunctival_pigmented_lesions [2026/02/25 19:41] – Scott Larsonconjunctival_pigmented_lesions [2026/02/25 19:50] (current) – Scott Larson
Line 1: Line 1:
 ====== Conjunctival Pigmented Lesions ====== ====== Conjunctival Pigmented Lesions ======
-FIXME+
 ====Nevi==== ====Nevi====
   * Usually appear in childhood   * Usually appear in childhood
Line 34: Line 34:
     * For diffuse disease or tarsal conjunctiva     * For diffuse disease or tarsal conjunctiva
       * Cryotherapy with double freeze-thaw       * Cryotherapy with double freeze-thaw
 +      * Topical interferon alpha-2b
       * Topical mytomycin C 0.02% or 0.04%       * Topical mytomycin C 0.02% or 0.04%
         * QID x 1 week          * QID x 1 week 
Line 69: Line 70:
   - [[https://www.aao.org/eyenet/article/conjunctival-pigmented-lesions-diagnosis-managemen |Conjunctival Pigmented Lesions: Diagnosis and Management. Sayaad FFE et al. Eyenet September 2013]]   - [[https://www.aao.org/eyenet/article/conjunctival-pigmented-lesions-diagnosis-managemen |Conjunctival Pigmented Lesions: Diagnosis and Management. Sayaad FFE et al. Eyenet September 2013]]
   - [[https://pubmed.ncbi.nlm.nih.gov/14711437/ |Tumors of the conjunctiva and cornea. Shields CL, Shields JA. Surv Ophthalmol. 2004;49(1):3-24]]   - [[https://pubmed.ncbi.nlm.nih.gov/14711437/ |Tumors of the conjunctiva and cornea. Shields CL, Shields JA. Surv Ophthalmol. 2004;49(1):3-24]]
 +  - [[https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S003962572200039X?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS003962572200039X%3Fshowall%3Dtrue&referrer=https:%2F%2Fpubmed.ncbi.nlm.nih.gov%2F| Use of interferon alpha 2b to manage primary acquired melanosis and conjunctival melanoma. Cid-Bertomeu P, et al. Surv Ophthalmol. 2022;67(5):1391-1404]]